Digital tech boosted Pfizer commercial, R&D gains during Covid — and there’s no going back, execs say
Pfizer went digital in a big way during the Covid pandemic — and it’s not going back, executives said at Cowen’s annual healthcare conference on Monday.
From clinical trials that used predictive modeling to pinpoint Covid surges to the use of artificial intelligence to monitor Corminarty vaccine freezer storage to complementary digital sales rep models, Pfizer adopted an accelerated raft of technologies that the Big Pharma plans to keep.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.